FDA — authorised 5 November 1976
- Status: approved
🇺🇸 Lopremone in United States
FDA authorised Lopremone on 5 November 1976
Marketing authorisations
FDA — authorised 18 July 1978
- Application: NDA018087
- Marketing authorisation holder: FERRING
- Local brand name: THYREL TRH
- Indication: INJECTABLE — INJECTION
- Status: approved
Lopremone in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Other approved in United States
Frequently asked questions
Is Lopremone approved in United States?
Yes. FDA authorised it on 5 November 1976; FDA authorised it on 18 July 1978.
Who is the marketing authorisation holder for Lopremone in United States?
Marketing authorisation holder not available in our data.